ANZGOG
The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is the peak national organisation for gynaecological cancer research in Australia and New Zealand. With more than 1,500 members spanning clinical, allied health and research fields, ANZGOG conducts world-class clinical trials and multidisciplinary studies aimed at improving the lives of those affected by gynaecological cancer.
Our trials are run at over 80 hospital sites across the region and include both local and international collaborations, ensuring women have access to the latest, most effective research.
WomenCan is the fundraising arm of ANZGOG, funding research and education programs conducted by ANZGOG’s membership. WomenCan’s mission is to engage with the community to fund pioneering discoveries that will enable women with gynaecological cancer to live better and live longer.
State of the Nation: Uterine Cancers 2025
ANZGOG's recurrent gynaecological clear cell carcinoma cancer trial DOVE
Underfunding in gynaecological cancer research is costing women their lives
Dr Michelle Harrison and attending 2025 ANZGOG ASM
WomenCan x Posisocks: an interview with ovarian cancer survivor, Michelle
WomenCan x Posisocks: Step up for Women
Tania Batley - what are the first steps towards equity in gynae cancer care?
Survivors Teaching Students - Educating the next generation of health professionals
Trusting your instinct - Kirsty's cervical cancer journey
Dr Bryony Simcock - challenges with Gynae Cancer in New Zealand
Alisha's Ovarian Cancer Story
ANZGOG’s endometrial cancer study ADELE
Endometrial cancer trial XPORT-EC-042
ANZGOG's Ovarian cancer signal-seeking study IGNITE
Dr Michelle Harrison talks about this year's landmark ANZGOG ASM
Dr Claire Henry - Why I'm excited for ANZGOG's 2024 ASM
5 Reasons Why You Should Attend ANZGOG's 2024 Annual Scientific Meeting - Prof Clare Scott AM
Bench to Bedside – The Power of Clinician-Scientist Collaboration
Survivors Teaching Students – Educating Doctors through the Power of Storytelling
What is TR-ANZGOG?
The rise of Endometrial cancer
EDEN: ANZGOG's Research Initiative
PARP inhibitors and ovarian cancer
ANZGOG 2023 Annual Scientific Meeting - Assoc Prof Yoland Antill